Press Releases

Date	Title
3/10/06	AVI BioPharma Incorporated 2005 Fourth Quarter and Year–End Financial Results Conference Call Transcript
3/8/06	AVI BioPharma Announces 2005 Fourth Quarter and Full Year Financial Results
3/7/06	AVI BioPharma Successful Ebola Study Results Highlighted in Nature Reviews Drug Discovery
3/1/06	AVI BioPharma Announces 2005 Fourth Quarter and Year End Financial Results Conference Call
2/9/06	Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine
1/27/06	AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron
1/20/06	AVI BioPharma Reports Confirmation of Efficacy against Influenza Strains
1/13/06	AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus
1/10/06	AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data From Its Clinical Trial Targeting Hepatitis C Virus
1/4/06	Increased Defense-Related Funding of AVI BioPharma Approved

IR Menu